Jingjing Sun

Jingjing Sun, PhD, is an Assistant Professor in the Department of Pharmaceutical Sciences at the University of Nebraska Medical Center (UNMC) College of Pharmacy. Her research integrates chemistry, bioinformatics, cancer biology, and immunology to develop nanocarriers for cancer therapy.

• Education: PhD in Polymer Chemistry and Physics from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
• Postdoctoral training: Pharmaceutics and Cancer Immunotherapy under Professor Song Li at University of Pittsburgh

Her research focuses on:

• Nanocarrier design for co-delivery of small molecules and nucleic acids (e.g., siRNA, miRNA)
• Overcoming clinical translation barriers in nanomedicine
• Mechanisms of nanomedicine-based cancer immunotherapy and targeted therapy
• Combination therapies (chemotherapy, immunotherapy, targeted therapy)
• Interaction between nanocarriers, therapeutics, and biological systems

The trends in her publications highlight interdisciplinary approaches to drug delivery, with emphasis on pancreatic and breast cancer, immune resistance modulation, co-delivery systems, and computational modeling for nanocarrier optimization. Her work spans polymer engineering, gene therapy, and synthetic lethal strategies.